HF Sinclair Corporation heads into its May 1 Q1 print with the market weighing a rare governance overhang against an otherwise cheap-looking refiner.
Options positioning is relaxed heading into the report. The put/call ratio came in at 0.71 on April 27, essentially flat with its 20-day average of 0.72 and well below last year's high of 1.47. That points to no meaningful demand for downside protection — a notable contrast with the governance uncertainty hanging over the name. Short sellers are equally uncommitted: SI % FF is a modest 3.6%, down roughly 10% over the past month even as it ticked up slightly in recent sessions. Borrow is near free at 0.41% annualised, and utilisation at under 3% is a fraction of its 52-week peak of 11.9%. The stock itself recovered 6.8% on the week to close at $61.80, paring a 3% monthly decline. No squeeze pressure, no aggressive positioning — the lending market is wide open.
The investment debate is unusually complicated for a mid-cycle refiner. The bull case rests on DINO's diversification: stable midstream earnings, a growing branded marketing business in the southwest, and what analysts broadly agree is attractive sum-of-the-parts valuation. Morgan Stanley raised its target to $66 this week while holding Overweight, and Raymond James carries a $75 Strong Buy target. At roughly 10x trailing earnings and 5.6x EV/EBITDA, neither multiple looks stretched for a diversified downstream operator. Bears, however, have a harder argument to dismiss: an audit committee review of the company's disclosure process and CEO Timothy Go's voluntary leave of absence in late 2025 introduce an overhang that pure valuation cannot resolve. Scotiabank downgraded the stock to Sector Perform late last year, and TD Cowen trimmed its target to $68 this morning while staying at Hold. The mean analyst target of $66.21 implies modest upside from current levels. Most of the Street has lifted targets in recent weeks — but the ratings themselves have barely moved, clustered in Hold and Equal-Weight territory.
The ownership picture adds a subtle layer of interest. The most significant recent institutional activity is Charles Schwab Investment Management adding over 4.8 million shares as of April 1, lifting its stake to 6.2% of shares outstanding — a meaningful accumulation. BlackRock and Vanguard hold the two largest positions at 11.5% and 9.3% respectively, both adding modestly. One notable counterweight: REH Advisors, which holds a 7% stake, sold nearly 1.4 million shares in late 2025. Insider data through December 2025 shows a cluster of executive sales — including CEO Go — at prices around $53, well below the current level.
Thursday's print will test whether HF Sinclair's Q1 refining margins held up against a volatile crude spread environment — and, perhaps more pointedly, whether management addresses the governance review with enough clarity to put it behind the stock.
See the live data behind this article on ORTEX.
Open DINO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
